Cochrane Abstracts
Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Impact of Low‐dose Computed Tomography (LDCT) Screening On Lung Cancer‐related Mortality." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438237/all/Impact_of_low‐dose_computed_tomography__LDCT__screening_on_lung_cancer‐related_mortality.
Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438237/all/Impact_of_low‐dose_computed_tomography__LDCT__screening_on_lung_cancer‐related_mortality. Accessed March 24, 2025.
Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438237/all/Impact_of_low‐dose_computed_tomography__LDCT__screening_on_lung_cancer‐related_mortality
Impact of Low‐dose Computed Tomography (LDCT) Screening On Lung Cancer‐related Mortality [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438237/all/Impact_of_low‐dose_computed_tomography__LDCT__screening_on_lung_cancer‐related_mortality.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality
ID - 438237
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438237/all/Impact_of_low‐dose_computed_tomography__LDCT__screening_on_lung_cancer‐related_mortality
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
